Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.

about

Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.

P2860

Q48229350-8FFEED78-8DA4-4503-8CC6-1D5DA438D19D

P2860

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.

Item

http://www.wikidata.org/entity/Q39442876

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Patient selection for cytoredu ...... stases from colorectal cancer.

@en

Patient selection for cytoredu ...... stases from colorectal cancer.

@nl

type

Item

label

Patient selection for cytoredu ...... stases from colorectal cancer.

@en

Patient selection for cytoredu ...... stases from colorectal cancer.

@nl

prefLabel

Patient selection for cytoredu ...... stases from colorectal cancer.

@en

Patient selection for cytoredu ...... stases from colorectal cancer.

@nl

P1476

Patient selection for cytoredu ...... stases from colorectal cancer.

@en

P2093

Geert A Simkens

http://www.w3.org/2001/XMLSchema#string

Ignace H de Hingh

http://www.w3.org/2001/XMLSchema#string

Koen P Rovers

http://www.w3.org/2001/XMLSchema#string

Simon W Nienhuijs

http://www.w3.org/2001/XMLSchema#string

P2860

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo.

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.

Peritoneal metastases of lower gastrointestinal tract origin:a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy

Pathological response grade of colorectal liver metastases treated with neoadjuvant chemotherapy

Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

Peritonectomy procedures.

Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.

Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis.

P304

259-266

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S119569

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28721098

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5501638

http://www.w3.org/2001/XMLSchema#string

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.

about

P2860

P2860

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P932